Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients (Certi-CMV)

Clinical Trial ID NCT00828503

PubWeight™ 1.57‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00828503

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990 5.66
2 American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006 2.11
3 Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000 1.90
4 New cell-signaling pathways for controlling cytomegalovirus replication. Am J Transplant 2014 0.81
5 Potential of protein kinase inhibitors for treating herpesvirus-associated disease. Trends Microbiol 2013 0.76
Next 100